SAP GxP (Good x Practice) refers to the use of regulated good practice standards within SAP systems , including system configuration, validation and governance processes aligned to industry regulations. The ‘x’ in GxP represents the specific area of practice being addressed.  

GxP compliance is a critical requirement in heavily regulated industries such as pharmaceuticals, biotechnology and medical devices and life sciences. These standards exist to ensure product quality, patient safety, data integrity and operational accountability. 

Failure to comply with GxP processes can result in serious legal and financial consequences, as well as risks to consumer safety. One notable example is Ranbaxy Laboratories, which agreed to a $500 million settlement in 2013 following allegations related to adulterated drugs and manufacturing operations. 

Regulatory Bodies Driving GxP Compliance

SAP GxP framework has been developed to support the requirements of major global regulatory authorities. These organizations establish standards and conduct inspections to ensure compliance across regulated industries. 

Key governing bodies include: 

• FDA (U.S. Food and Drug Administration) – sets GxP standards for the US and conducts inspections to ensure compliance.  
• EMA (European Medicines Agency) – serves the EU, provides guidelines, conducts assessments, and collaborates globally to harmonize GxP standards.  
• WHO (World Health Organization) - provides global guidelines to maintain international health standards.   

Life Sciences organizations are among the most common users of SAP GxP environments due to the highly regulated nature of the industry. 

Common GxP Standards in Pharmaceuticals 

There are several different Good Practice standards used across pharmaceutical and life sciences organizations, each focusing on different areas.

Good Manufacturing Practice or GMP – provides structure on how products are consistently produced and quality controlled throughout the manufacturing process.  

• Good Documentation Practice or GDP – is a set of standards that define how records should be created, handled, maintained and made available to ensure data integrity and traceability for audit purposes.  
• Good Clinical Practice or GCP – standards and quality requirements for operating clinical trials involving humans.   
• Good Laboratory Practice or GLP – provides a set of quality and integrity standards for adoption by lab studies.  

Core Regulatory Expectations Within SAP Environments 

Organizations operating under SAP environments must be able to demonstrate several core compliance capabilities regardless of the specific GxP area involved. 

• Computer System validation (CSV) - a continuous activity, involving risk assessments, testing and maintaining a validated system state at all times. This ensures the system reliably performs as intended.   
• Traceability – full visibility into the product lifecycle from individual raw materials, manufacture, testing and distribution. Especially helpful in the event of audit or recall where questions such as what was used, who was involved at each stage and under what conditions was the batch produced could be faced.   
• Electronic signatures – under regulations like 21 CFR, electronic signatures must have the same authorization as a handwritten one. This ensures accountability for approvals and system changes made.   
• Data integrity - following the ALCOA+ principles: Attributable, Legible, Contemporaneous, Original, and Accurate.   
• Audit trails - every change to GxP-relevant data must be logged and time stamped.  
• Access control – having segregation of duties and role-based authorizations in place is a must.   

Every data point recorded, every system change and every pallet of product must be governed, documented and made defensible to regulators. SAP continues to be the dominant vendor for Life Sciences because of its ability to provide the technical capabilities and configuration to meet the regulation demands of the industry.  

SAP GxP Licensing and S/4HANA 

GxP capabilities are available through SAP S/4HANA Cloud for GxP, Private Edition, which provides Life Sciences and other GxP industries with a validated and regulation ready private environment. The environment can be further extended through integration with SAP Business Technology Platform where additional data workflow, automation, analytics and connectivity privileges are given with other GxP-relevant systems.  

Because the GxP add-on is priced as a percentage of the net recurring fee (of applicable GxP solutions), any discount you achieve on the base RISE/SAP Cloud ERP Private subscription automatically reduces your GxP add-on cost proportionally - which makes the base negotiation and rightsizing of your future software estate especially important for life sciences and customers in high regulation industries.   

Final Thoughts 

As regulatory expectations continue to evolve, organizations must ensure their SAP environments remain compliant, secure, and audit ready. 

For Life Sciences and other regulated industries, SAP provides the technical capabilities required to support validation, traceability, governance, and long-term compliance management across critical business operations.